BIOCLARMA SRL of Torino at MEDICA 2019 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option
Manufacturers Trader Service OEM

BIOCLARMA SRL

Via Nizza, 52, 10126 Torino
Italy
Telephone +39 348 4078385
Fax +39 011 6708416
info@bioclarma.com

This company is co-exhibitor of
CEIPIEMONTE S.C.p.A. / PIEMONTE AGENCY

Hall map

MEDICA 2019 hall map (Hall 16): stand A42

Fairground map

MEDICA 2019 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.04  Other molecular diagnostics testing

Our products

Product category: Other molecular diagnostics testing

Gene Specific FISH Probes

Gene Specific probes are designed to hybridize to a precise gene location. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads. Gene specific probes are available in both single and dual colors. ASR and CE marked gene specific probes are available.

More Less

Product category: Other molecular diagnostics testing

Acute Lymphoblastic Leukemia FISH Probes

The following Fluorescence In Situ Hybridization (FISH) probes can be used use to identify aberrations of genes clinically relevant to Acute Lymphoblastic Leukemia. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads. These probes are available in both single and dual colors. ASR and CE marked gene specific probes are available.

More Less

Product category: Other molecular diagnostics testing

1p21.1 FISH Probes

Find FISH probes that cover the 1p21.1 region on chromosome 1.

More Less

About us

Company details

Empire Genomics designs, manufactures and distributes more than one million clinical and custom labeled molecular probes, enabling hundreds of leading global clinical laboratories, biotechnology organizations and academic institutions to advance biomarker research, accelerate diagnoses and improve personalized treatment options for patients battling cancer and other complex diseases. The company was founded in 2006 by Norma J. Nowak, PhD, a prominent member of the Human Genome Project, to utilize innovative research started at the prestigious Roswell Park Cancer Institute in Buffalo, New York. The comprehensive product portfolio includes Fluorescence in Situ Hybridization (FISH) and Chromogenic in Situ Hybridization (CISH) probes that are designed and optimized for specific diseases, genes, and/or regions across the entire human or mouse genomes.

More Less